2012—2014年某院干部门诊口服降糖药应用分析  

Analysis of oral hypoglycemic drugs in cadre clinic of a hospital from 2012 to 2014

作　　者：阙万才[1] 郑键[2] 

机构地区：[1]福建医科大学附属协和医院药学部,福建福州350001 [2]福建医科大学附属第一医院药学部,福建福州350001

出　　处：《中国医院药学杂志》2016年第18期1593-1598,共6页Chinese Journal of Hospital Pharmacy

摘　　要：目的:对某院干部门诊口服降糖药的应用情况进行分析,提供临床合理用药的参考。方法:随机抽取2012—2014年某院干部门诊2型糖尿病患者处方2 108份,采用限定日剂量(DDD)法,对其使用的口服降糖药的药品种类、限定日费用(DDC)、用药频度(DDDs)、药物利用指数(DUI)、销售金额及其联合用药情况进行统计分析。结果:该院干部门诊口服降糖药销售金额逐年上升,阿卡波糖销售金额连续3年排在首位,二甲双胍、阿卡波糖、瑞格列奈DDDs值连续3年名列前三,除格列吡嗪(缓释)、瑞格列奈、罗格列酮外其余药物DUI值≤1。结论:该院干部门诊口服降糖药应用基本合理。OBJECTIVE To investigate use of oral hypoglycemic drugs in cadre clinic of a hospital,and provide a reference for rational drug use.METHODS A total of 2108 prescriptions for type 2 diabetes patients from2012 to 2014 were randomly sampled to respectively analyze oral hypoglycemic agents used in our hospital in aspects of variety,consumption sum,DDDs,DDC,DUI and combined drugs,etc.RESULTS Consumption sum of oral hypoglycemic agents in hospital increased continuously.Acarbose ranked the first of consumption sum for three consecutive years.Top 3 medicines on list of DDDs were metformine,acarbose and repaglinide.DUIs of all oral hypoglycemic agents was less than or equal to 1 except glipizide（slow release）,repaglinide and rosiglitazone.CONCLUSION Use of oral hypoglycemic drugs in cadre clinic of the hospital is basically reasonable.

关 键 词：口服降糖药 用药频度 药物利用指数 联合用药 

分 类 号：R977[医药卫生—药品]